Discover 1,087 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,087
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
for
Epilepsy, Temporal Lobe
Location: Syracuse NY, Charlottesville VA, Durham NC,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06422923
Phase 1, Phase 2, Recruiting
NIBP Validation Study
for
Critical Illness
Location: Winston-Salem NC, San Antonio TX, Portland OR
Sponsor: Philips Clinical & Medical Affairs Global
Sex: All
Age: 0+
Code: NCT05673408
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
for
Growth Hormone Deficiency
Location: Manchester NH, Lebanon NH, New Hyde Park NY,
Location: Boston MA, New York NY, Wake Forest NC, Gainesville FL,
Sponsor: Hospital for Special Surgery, New York
Sex: All
Age: 10 - 35
Code: NCT06883396
Recruiting
Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
for
Acute Myeloid Leukemia
Location: Dallas TX, Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT04659616
Phase 1, Recruiting
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
for
Acute Stroke, Ischemic Stroke, Stroke
Location: Worcester MA, New York NY, Philadelphia PA,
Sponsor: DiaMedica Therapeutics Inc
Sex: All
Age: 18 - 70+
Code: NCT05065216
Phase 2, Phase 3, Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Boston MA, Lake Success NY, The Bronx NY, Brooklyn NY,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase 3, Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: Boston MA, New York NY, Fairfax VA, Tampa FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05768139
Phase 1, Phase 2, Recruiting
The Omeza Protocol for Chronic Ulcers
for
Venous Leg Ulcer, Diabetic Foot Ulcer
Location: Newark NJ, Jacksonville FL, Dallas TX, Portland OR
Sponsor: Omeza, LLC
Sex: All
Age: 21 - 70+
Code: NCT04198441
Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Boston MA, Guilford CT, Hartford CT, North Haven CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase 3, Recruiting
Mechanisms of Depression and Anhedonia in Adolescents: Linking Sleep to Reward- and Stress-Related Brain Function